Astellas to Acquire Ocata Therapeutics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Astellas Pharma Inc Unsponsored ADR (AMEX: ALPMY) | Delayed: 15.95 +0.18 (1.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.77 | 52 Week High | $19.40 | |||
| Open | $15.90 | 52 Week Low | $12.50 | |||
| Day High | $15.99 | P/E | N/A | |||
| Day Low | $15.52 | EPS | $0.00 | |||
| Volume | 95,873 | |||||
| (NASDAQ: OCAT) | Delayed: 8.47 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.47 | 52 Week High | $8.71 | |||
| Open | $11.52 | 52 Week Low | $3.06 | |||
| Day High | $8.47 | P/E | N/A | |||
| Day Low | $8.47 | EPS | $0.00 | |||
| Volume | 9,796 | |||||
